This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As many of you know, hospitals and health systems have emerged as significant participants in the specialtypharmacy industry. A new American Society of Hospital Pharmacists (ASHP) survey provides fresh insights into these specialtypharmacies. drug channels gets most of the attention.
Hospitals and health systems are rapidly expanding their internal specialtypharmacies—and they’re using questionable tactics to boost revenues and profits. Nearly two-thirds of the larger health system specialtypharmacies operate as the exclusive pharmacy within self-insured health systems’ networks.
National Association of SpecialtyPharmacy (NASP) 2022 Annual Meeting & Expo. The National Association of SpecialtyPharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. Drug Channels, or any of its employees. d/b/a Drug Channels Institute. www.naspnet.org/annualmeeting.
Informa Connect's Hub and SpecialtyPharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Drug Channels readers will save 10% off the current registration rate when they use code 22DC10 *. d/b/a Drug Channels Institute.
specialtypharmacies—via white, brown, and clear bagging—continue to displace buy-and-bill distribution channels for provider-administered oncology drugs. The battle for the specialty patient pits hospitals against insurers—and their respective specialtypharmacies. d/b/a Drug Channels Institute.
In Drug Channels Institute’s list of the top 15 pharmacies of 2022 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. d/b/a Drug Channels Institute. d/b/a Drug Channels Institute.
In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. This week, I’m attending Asembia’s SpecialtyPharmacy Summit.
Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialtypharmacy market continue to get more diverse—although revenues remain highly concentrated. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialtypharmacy trends.
Yesterday’s reflections on Asembia’s SpecialtyPharmacy Summit included a link to the general session slides. My portion of the deck included an updated mapping of vertical integration among insurers, PBMs, specialtypharmacies, and providers within U.S. drug channels. d/b/a Drug Channels Institute.
It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialtypharmacies, and providers within U.S. drug channels. But until anyone takes action, we will continue to live with the golden rule of the drug channel: Whoever has the gold gets to make the rules.
Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022 SpecialtyPharmacy Summit at the wonderful Wynn Las Vegas. I offer reflections on my keynote session with Scott Gottlieb, share my experiences during the featured session, and highlight three crucial specialty industry trends. d/b/a Drug Channels Institute.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: SpecialtyDrugs Update: Trends, Controversies, and Outlook. To complement that broader ranking, we present below our exclusive and updated list of the top 15 pharmacies based on specialtydrug dispensing revenues in 2021.
The other is my mapping of the insurer/PBM/specialtypharmacy/provider organizations that now dominate U.S. drug channels. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. One is my chart showing the key channel flows within the entire U.S. About half of all U.S.
Informa Connect’s Hub and SpecialtyPharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. Drug Channels readers will save 10% off the current registration rate when they use code 22DC10*. Drug Channels, or any of its employees.
Asembia’s SpecialtyPharmacy Summit 2022. Asembia's SpecialtyPharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialtypharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The SpecialtyPharmacy Industry Update and Outlook.
Jayne discusses changes in the life science and specialtypharmacy industries since the COVID-19 pandemic began. She highlights three key trends that pharma companies, plan sponsors, and others will consider as we head to the upcoming Asembia SpecialtyPharmacy Summit (October 26 to 29 in Las Vegas).
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Last week, we documented the substantial concentration of dispensing revenues for specialtydrugs. Click here to see the original post from April 2024.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. d/b/a Drug Channels Institute.
Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Happy Thanksgiving, everyone! to 1:30 p.m. Will you be there, too?
Hospitals and health systems are building a major presence in the specialtypharmacy industry. As we demonstrate below, nine out of ten large hospitals now operate a specialtypharmacy. accredited specialtypharmacies. d/b/a Drug Channels Institute.
This Valentine's Day, what could be more romantic than a deep dive into the relationships between manufacturers of specialtydrugs and the pharmacies they choose for their limited and exclusive specialtypharmacy networks. As you’ll see, a typical network contains only five specialtypharmacies.
Last week, we documented the substantial concentration of dispensing revenues for specialtydrugs. See The Top 15 SpecialtyPharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. Today, we examine how manufacturers’ specialty networks contribute to this concentration.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon Plus, the FDA preps you for Thursday with a regulatory soup review. d/b/a Drug Channels Institute.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. In Drug Channels Institute's list of the top 15 pharmacies of 2020 , we show that many of the largest U.S. d/b/a Drug Channels Institute. Read on for all the details.
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialtypharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Consequently, its market share is closer to 10%, compared with the 3% that we reported.
It’s time for Drug Channels Institute’s annual update of the number of U.S. specialtypharmacies. As you will note below, the specialtypharmacy industry remains quite diverse— despite the concentration of dispensing revenues within a small number of companies. d/b/a Drug Channels Institute.
In May, I recorded a brief video webinar for an on-demand business education session at Asembia's 2020 SpecialtyPharmacy Summit Virtual Experience. Pharmacies and Pharmacy Benefit Managers. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialtypharmacies within 340B. As you will see below, these specialtypharmacies have dramatically increased their participation in the 340B program. d/b/a Drug Channels Institute.
The battle for control of the specialty patient continues. In 2022, specialtypharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. d/b/a Drug Channels Institute. Read on for full details and the latest data.
In this clip, I highlight the growth and consolidation dynamics facing the specialtypharmacy industry. I also discuss the competitive challenges facing smaller pharmacies. Never fear, Drug Channels traditionalists. d/b/a Drug Channels Institute. I'll be back with a new article next week.
Will COVID-19 trigger long-term share gains for specialtypharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialtypharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialtydrugs.
In Drug Channels Institute's list of the top 15 pharmacies of 2019 , we show that many of the largest U.S. pharmacies are now central-fill mail and specialtypharmacies operated by PBMs and insurers. I see upside for specialtypharmacies in the aftermath of the pandemic.
National Association of SpecialtyPharmacy (NASP) 2021 Annual Meeting & Expo. The National Association of SpecialtyPharmacy (NASP) returns to Washington, D.C. on September 27-30 for the National Association of SpecialtyPharmacy (NASP) 2021 Annual Meeting & Expo. d/b/a Drug Channels Institute.
Today’s guest post comes from Megan Marchal, Director of SpecialtyPharmacy Strategy at CoverMyMeds. Megan discusses the access and affordability challenges faced by specialty therapy patients. Click here to sign up for CoverMyMeds’ Asembia SpecialtyPharmacy Summit recaps. d/b/a Drug Channels Institute.
This week, I’m rerunning some popular posts while I prepare for today's video webinar: Drug Channels Outlook 2021. Will COVID-19 trigger long-term share gains for specialtypharmacies as suppliers to hospitals and physician offices? d/b/a Drug Channels Institute. Read on and see if you agree.
Next week, I'll be live and in-person at Asembia's SpecialtyPharmacy Summit. During Tuesday's general session, I'll be joining Dr. Scott Gottlieb for a fireside chat at 8:00 AM and will then present my "State of SpecialtyPharmacy 2022" at 9:30 AM. d/b/a Drug Channels Institute.
This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. spending on healthcare.
Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialtypharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.
Like many of you, I was disappointed that Asembia had to cancel its 2020 SpecialtyPharmacy Summit. You can view them for FREE if your registration to the 2020 SpecialtyPharmacy Summit was transferred to the 2021 Summit. Click here to register for access to Asembia’s SpecialtyPharmacy Summit Virtual Experience.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m. WHAT YOU WILL LEARN.
Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@DrugChannels.net).
Today’s guest post comes from Megan Marchal, Director of SpecialtyPharmacy Strategy at CoverMyMeds. Megan discusses upcoming specialty medication launches. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Megan’s insights.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content